This HTML5 document contains 186 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0144190/price-of-originator/
n18http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0144190/reimbursement/
n3http://linked.opendata.cz/ontology/sukl/
n7http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0144190/
n13http://linked.opendata.cz/resource/sukl/specialization-restriction/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0144190/core-reimbursement/
n19http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0144190/price/
skoshttp://www.w3.org/2004/02/skos/core#
n6http://linked.opendata.cz/resource/sukl/indgroup/
n15http://linked.opendata.cz/resource/sukl/packing/
n16http://linked.opendata.cz/resource/sukl/company/
n21http://linked.opendata.cz/resource/sukl/active-ingredient/
n9http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n17http://linked.opendata.cz/resource/sukl/registration-state/
xsdhhttp://www.w3.org/2001/XMLSchema#
n20http://www.sukl.cz/modules/medication/
n14http://linked.opendata.cz/resource/atc/
n11http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item
n2:0144190
rdf:type
n3:MedicinalProductPackaging
dcterms:title
BETAHISTIN MYLAN 16 MG
skos:notation
0144190
n3:hasATCCode
n14:N07CA01
n3:hasActiveIngredient
n21:BETAHISTINI-DIHYDROCHLORIDUM
n3:hasDefinedDailyDose
n7:ddd
n3:hasDosageForm
n11:TBL-NOB-POR
n3:hasPackagingSize
60
n3:hasPacking
n15:BLI
n3:hasRegistrationHolder
n16:GNSGB
n3:hasRegistrationState
n17:R
n3:hasRouteOfAdministration
n10:POR
n3:hasStrength
16MG
n3:hasIndicationGroup
n6:83
n3:hasSpecializationRestriction
n9:blank-cell n13:ORL n13:NEU
n3:containsDefinedDailyDoses
40.0
n3:hasRegistrationCode
83/ 375/08-C
n3:hasTitleSupplement
POR TBL NOB 60X16MG
n3:containsUsualTherapeuticalDailyDoses
20
n3:hasCoreReimbursementSpecification
n4:2014-10-01 n4:2014-07-03 n4:2014-08-01 n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2013-04-01 n4:2013-05-01 n4:2013-02-01 n4:2013-03-01 n4:2013-01-01 n4:2013-01-05 n4:2015-07-01 n4:2015-07-02 n4:2015-05-01 n4:2015-06-01 n4:2015-04-01 n4:2015-04-02 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2014-09-01
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n5:2013-01-01 n5:2013-01-05 n5:2013-04-01 n5:2013-05-01 n5:2013-02-01 n5:2013-03-01 n5:2013-08-01 n5:2013-08-03 n5:2013-06-01 n5:2013-07-01 n5:2013-11-01 n5:2013-12-01 n5:2013-09-01 n5:2013-10-01 n5:2014-03-01 n5:2014-04-01 n5:2014-01-01 n5:2014-02-01 n5:2014-06-13 n5:2014-07-01 n5:2014-05-01 n5:2014-06-01 n5:2014-09-01 n5:2014-10-01 n5:2014-07-03 n5:2014-08-01 n5:2014-11-19 n5:2014-12-01 n5:2014-10-02 n5:2014-11-01 n5:2015-02-01 n5:2015-03-01 n5:2015-01-01 n5:2015-01-13 n5:2015-05-01 n5:2015-06-01 n5:2015-04-01 n5:2015-04-02 n5:2015-07-01 n5:2015-07-02
n3:hasPriceSpecification
n19:2014-05-01 n19:2014-06-01 n19:2014-06-13 n19:2014-07-01 n19:2014-01-01 n19:2014-02-01 n19:2014-03-01 n19:2014-04-01 n19:2014-10-02 n19:2014-11-01 n19:2014-11-19 n19:2014-12-01 n19:2014-07-03 n19:2014-08-01 n19:2014-09-01 n19:2014-10-01 n19:2015-04-01 n19:2015-04-02 n19:2015-05-01 n19:2015-06-01 n19:2015-01-01 n19:2015-01-13 n19:2013-02-01 n19:2015-02-01 n19:2013-03-01 n19:2015-03-01 n19:2013-04-01 n19:2013-05-01 n19:2013-01-01 n19:2013-01-05 n19:2015-07-01 n19:2013-09-01 n19:2015-07-02 n19:2013-10-01 n19:2013-11-01 n19:2013-12-01 n19:2013-06-01 n19:2013-07-01 n19:2013-08-01 n19:2013-08-03
n3:hasReimbursementSpecification
n18:2015-07-01 n18:2015-07-02 n18:2013-11-01 n18:2013-12-01 n18:2013-09-01 n18:2013-10-01 n18:2013-08-01 n18:2013-08-03 n18:2013-06-01 n18:2013-07-01 n18:2014-06-13 n18:2014-07-01 n18:2014-05-01 n18:2014-06-01 n18:2014-03-01 n18:2014-04-01 n18:2014-01-01 n18:2014-02-01 n18:2014-11-19 n18:2014-12-01 n18:2014-10-02 n18:2014-11-01 n18:2014-09-01 n18:2014-10-01 n18:2014-07-03 n18:2014-08-01 n18:2015-05-01 n18:2015-06-01 n18:2015-04-01 n18:2015-04-02 n18:2015-02-01 n18:2015-03-01 n18:2015-01-01 n18:2015-01-13 n18:2013-04-01 n18:2013-05-01 n18:2013-02-01 n18:2013-03-01 n18:2013-01-01 n18:2013-01-05
n3:hasResumedMarketingDate
2009-10-01+02:00
n3:hasUsualTherapeuticalDailyDose
n7:utdd
n3:spcFile
http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC46922.pdf%26type%3Dspc%26as%3Dbetahistin-mylan-16-mg-spc
n3:spcUri
n20:download.php?file=SPC46922.pdf&type=spc&as=betahistin-mylan-16-mg-spc